-
10x Genomics Inc. (TXG $13.08)
- $13.08 Cap: $1.61B
- View TXG Profile
- View Questions on TXG
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Illumina Inc. (ILMN $94.66)
- $94.66 Cap: $14.98B
- View ILMN Profile
- View Questions on ILMN
-
Pacific Biosciences of California Inc. (PACB $1.33)
- $1.33 Cap: $447M
- View PACB Profile
- View Questions on PACB
-
CRISPR Therapeutics AG (CRSP $56.09)
- $56.09 Cap: $4.84B
- View CRSP Profile
- View Questions on CRSP
-
Bio-Techne Corp (TECH $54.89)
- $54.89 P/E (TTM): 65.94X Cap: $9.04B
- View TECH Profile
- View Questions on TECH
-
10x Genomics Inc. (TXG $13.08)
- $13.08 Cap: $1.61B
- View TXG Profile
- View Questions on TXG
Q: Can you recommend stocks or ETFs in Multiomic sequencing
-
Parex Resources Inc. (PXT $15.95)
- $15.95 P/E (TTM): 14.82X Cap: $1.55B
- View PXT Profile
- View Questions on PXT
-
Cal-Maine Foods Inc. (CALM $107.88)
- $107.88 P/E (TTM): 4.45X Cap: $5.23B
- View CALM Profile
- View Questions on CALM
-
Clairvest Group Inc. (CVG $75.00)
- $75.00 P/E (TTM): 13.0X Cap: $1.06B
- View CVG Profile
- View Questions on CVG
-
Kulicke and Soffa Industries Inc. (KLIC $32.31)
- $32.31 P/E (TTM): 90.25X Cap: $1.70B
- View KLIC Profile
- View Questions on KLIC
-
Dundee Precious Metals Inc. (DPM $23.98)
- $23.98 P/E (TTM): 12.4X Cap: $4.01B
- View DPM Profile
- View Questions on DPM
-
Hollysys Automation Technologies Ltd. (HOLI)
- Cap: $1.63B
- View HOLI Profile
- View Questions on HOLI
-
Mueller Industries Inc. (MLI $83.34)
- $83.34 P/E (TTM): 13.55X Cap: $9.68B
- View MLI Profile
- View Questions on MLI
-
Encore Wire Corporation (WIRE)
- P/E (TTM): 15.22X Cap: $4.57B
- View WIRE Profile
- View Questions on WIRE
-
10x Genomics Inc. (TXG $13.08)
- $13.08 Cap: $1.61B
- View TXG Profile
- View Questions on TXG
-
Coveo Solutions Inc. Subordinate voting shares (CVO $8.37)
- $8.37 Cap: $805M
- View CVO Profile
- View Questions on CVO
Q: I am looking for cash-rich stocks with unusually low prices at the moment.
Could you recommend 5 Canadian and 5 US stocks
Thanks
Could you recommend 5 Canadian and 5 US stocks
Thanks
-
Exact Sciences Corporation (EXAS $47.76)
- $47.76 Cap: $9B
- View EXAS Profile
- View Questions on EXAS
-
Invitae Corporation (NVTA)
- Cap: $5M
- View NVTA Profile
- View Questions on NVTA
-
CRISPR Therapeutics AG (CRSP $56.09)
- $56.09 Cap: $4.84B
- View CRSP Profile
- View Questions on CRSP
-
Guardant Health Inc. (GH $41.42)
- $41.42 Cap: $5.16B
- View GH Profile
- View Questions on GH
-
Twist Bioscience Corporation (TWST $33.68)
- $33.68 Cap: $2.01B
- View TWST Profile
- View Questions on TWST
-
Intellia Therapeutics Inc. (NTLA $11.49)
- $11.49 Cap: $1.19B
- View NTLA Profile
- View Questions on NTLA
-
10x Genomics Inc. (TXG $13.08)
- $13.08 Cap: $1.61B
- View TXG Profile
- View Questions on TXG
-
DermTech Inc (DMTK)
- Cap: $3M
- View DMTK Profile
- View Questions on DMTK
Q: Looking at companies in these companies, some have more current business (EXAS) while others are based more on potential. Can you please rank each in order based on these two approaches:
1. Most growth potential
2. Best overall investment
Please comment briefly on why you would place a particular company as "Best in class" for approach 1 and 2.
1. Most growth potential
2. Best overall investment
Please comment briefly on why you would place a particular company as "Best in class" for approach 1 and 2.
Insiders
Share Information
SEC Filings
News and Media